{"id":31950,"date":"2025-04-17T19:17:08","date_gmt":"2025-04-17T11:17:08","guid":{"rendered":"https:\/\/flcube.com\/?p=31950"},"modified":"2025-04-17T19:17:36","modified_gmt":"2025-04-17T11:17:36","slug":"da-ren-tang-sells-stake-in-tianjin-shike-to-haleon-for-rmb-1-623-billion","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=31950","title":{"rendered":"Da Ren Tang Sells Stake in Tianjin Shike to Haleon for RMB 1.623 Billion"},"content":{"rendered":"\n

Tianjin Pharmaceutical Da Ren Tang Group Co., Ltd. (SHA: 600329<\/a>), a traditional Chinese medicine (TCM) enterprise, has completed the transfer of its 4.6% and 7.4% equity stakes in Tianjin Shike Pharmaceutical Co., Ltd. to Haleon (China) Co., Ltd. and Haleon CH SARL for RMB 622 million (USD 85 million) and RMB 1.001 billion (USD 137 million), respectively. The transaction is expected to impact Da Ren Tang\u2019s current investment income by approximately RMB 1.54 billion (USD 211 million). <\/p>\n\n\n\n

Transaction Details<\/strong>
Da Ren Tang has divested its remaining 12% stake in Tianjin Shike Pharmaceutical, originally a joint venture established by GlaxoSmithKline plc (GSK, NYSE: GSK<\/a>), Da Ren Tang (formerly Tianjin Zhongxin Pharmaceutical Group Co., Ltd.), and Tianjin Pacific Group. Following GSK\u2019s 2022 spin-off of its consumer healthcare business into Haleon plc (LON: HLN<\/a>), which controls both Haleon (China) and Haleon CH SARL, this transaction marks Da Ren Tang\u2019s full exit from the joint venture.<\/p>\n\n\n\n

Market and Financial Impact<\/strong>
The transaction not only concludes Da Ren Tang\u2019s involvement in Tianjin Shike but also reflects broader trends in the consumer health products market, where companies are restructuring to focus on core competencies. The financial gain from this divestment positions Da Ren Tang to explore new investment opportunities and strategic initiatives.-Fineline Info & Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Tianjin Pharmaceutical Da Ren Tang Group Co., Ltd. (SHA: 600329), a traditional Chinese medicine (TCM)…<\/p>\n","protected":false},"author":1,"featured_media":31953,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[4005,278,184,4008,4009,914,4006,4007],"class_list":["post-31950","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-da-ren-tang","tag-glaxosmithkline","tag-gsk","tag-haleon","tag-lon-hln","tag-nyse-gsk","tag-sha-600329","tag-shike-pharmaceutical"],"yoast_head":"\nDa Ren Tang Sells Stake in Tianjin Shike to Haleon for RMB 1.623 Billion - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Tianjin Pharmaceutical Da Ren Tang Group Co., Ltd. (SHA: 600329), a traditional Chinese medicine (TCM) enterprise, has completed the transfer of its 4.6% and 7.4% equity stakes in Tianjin Shike Pharmaceutical Co., Ltd. to Haleon (China) Co., Ltd. and Haleon CH SARL for RMB 622 million (USD 85 million) and RMB 1.001 billion (USD 137 million), respectively. The transaction is expected to impact Da Ren Tang\u2019s current investment income by approximately RMB 1.54 billion (USD 211 million).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=31950\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Da Ren Tang Sells Stake in Tianjin Shike to Haleon for RMB 1.623 Billion\" \/>\n<meta property=\"og:description\" content=\"Tianjin Pharmaceutical Da Ren Tang Group Co., Ltd. (SHA: 600329), a traditional Chinese medicine (TCM) enterprise, has completed the transfer of its 4.6% and 7.4% equity stakes in Tianjin Shike Pharmaceutical Co., Ltd. to Haleon (China) Co., Ltd. and Haleon CH SARL for RMB 622 million (USD 85 million) and RMB 1.001 billion (USD 137 million), respectively. The transaction is expected to impact Da Ren Tang\u2019s current investment income by approximately RMB 1.54 billion (USD 211 million).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=31950\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-17T11:17:08+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-17T11:17:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/1704.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31950#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31950\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Da Ren Tang Sells Stake in Tianjin Shike to Haleon for RMB 1.623 Billion\",\"datePublished\":\"2025-04-17T11:17:08+00:00\",\"dateModified\":\"2025-04-17T11:17:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31950\"},\"wordCount\":216,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31950#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/1704.webp\",\"keywords\":[\"Da Ren Tang\",\"GlaxoSmithKline\",\"GSK\",\"Haleon\",\"LON: HLN\",\"NYSE: GSK\",\"SHA: 600329\",\"Shike Pharmaceutical\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=31950#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31950\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=31950\",\"name\":\"Da Ren Tang Sells Stake in Tianjin Shike to Haleon for RMB 1.623 Billion - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31950#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31950#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/1704.webp\",\"datePublished\":\"2025-04-17T11:17:08+00:00\",\"dateModified\":\"2025-04-17T11:17:36+00:00\",\"description\":\"Tianjin Pharmaceutical Da Ren Tang Group Co., Ltd. (SHA: 600329), a traditional Chinese medicine (TCM) enterprise, has completed the transfer of its 4.6% and 7.4% equity stakes in Tianjin Shike Pharmaceutical Co., Ltd. to Haleon (China) Co., Ltd. and Haleon CH SARL for RMB 622 million (USD 85 million) and RMB 1.001 billion (USD 137 million), respectively. The transaction is expected to impact Da Ren Tang\u2019s current investment income by approximately RMB 1.54 billion (USD 211 million).\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31950#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=31950\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31950#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/1704.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/1704.webp\",\"width\":1080,\"height\":608,\"caption\":\"Da Ren Tang Sells Stake in Tianjin Shike to Haleon for RMB 1.623 Billion\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31950#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Da Ren Tang Sells Stake in Tianjin Shike to Haleon for RMB 1.623 Billion\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Da Ren Tang Sells Stake in Tianjin Shike to Haleon for RMB 1.623 Billion - Insight, China's Pharmaceutical Industry","description":"Tianjin Pharmaceutical Da Ren Tang Group Co., Ltd. (SHA: 600329), a traditional Chinese medicine (TCM) enterprise, has completed the transfer of its 4.6% and 7.4% equity stakes in Tianjin Shike Pharmaceutical Co., Ltd. to Haleon (China) Co., Ltd. and Haleon CH SARL for RMB 622 million (USD 85 million) and RMB 1.001 billion (USD 137 million), respectively. The transaction is expected to impact Da Ren Tang\u2019s current investment income by approximately RMB 1.54 billion (USD 211 million).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=31950","og_locale":"en_US","og_type":"article","og_title":"Da Ren Tang Sells Stake in Tianjin Shike to Haleon for RMB 1.623 Billion","og_description":"Tianjin Pharmaceutical Da Ren Tang Group Co., Ltd. (SHA: 600329), a traditional Chinese medicine (TCM) enterprise, has completed the transfer of its 4.6% and 7.4% equity stakes in Tianjin Shike Pharmaceutical Co., Ltd. to Haleon (China) Co., Ltd. and Haleon CH SARL for RMB 622 million (USD 85 million) and RMB 1.001 billion (USD 137 million), respectively. The transaction is expected to impact Da Ren Tang\u2019s current investment income by approximately RMB 1.54 billion (USD 211 million).","og_url":"https:\/\/flcube.com\/?p=31950","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-04-17T11:17:08+00:00","article_modified_time":"2025-04-17T11:17:36+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/1704.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=31950#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=31950"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Da Ren Tang Sells Stake in Tianjin Shike to Haleon for RMB 1.623 Billion","datePublished":"2025-04-17T11:17:08+00:00","dateModified":"2025-04-17T11:17:36+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=31950"},"wordCount":216,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=31950#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/1704.webp","keywords":["Da Ren Tang","GlaxoSmithKline","GSK","Haleon","LON: HLN","NYSE: GSK","SHA: 600329","Shike Pharmaceutical"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=31950#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=31950","url":"https:\/\/flcube.com\/?p=31950","name":"Da Ren Tang Sells Stake in Tianjin Shike to Haleon for RMB 1.623 Billion - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=31950#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=31950#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/1704.webp","datePublished":"2025-04-17T11:17:08+00:00","dateModified":"2025-04-17T11:17:36+00:00","description":"Tianjin Pharmaceutical Da Ren Tang Group Co., Ltd. (SHA: 600329), a traditional Chinese medicine (TCM) enterprise, has completed the transfer of its 4.6% and 7.4% equity stakes in Tianjin Shike Pharmaceutical Co., Ltd. to Haleon (China) Co., Ltd. and Haleon CH SARL for RMB 622 million (USD 85 million) and RMB 1.001 billion (USD 137 million), respectively. The transaction is expected to impact Da Ren Tang\u2019s current investment income by approximately RMB 1.54 billion (USD 211 million).","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=31950#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=31950"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=31950#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/1704.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/1704.webp","width":1080,"height":608,"caption":"Da Ren Tang Sells Stake in Tianjin Shike to Haleon for RMB 1.623 Billion"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=31950#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Da Ren Tang Sells Stake in Tianjin Shike to Haleon for RMB 1.623 Billion"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/1704.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/31950","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=31950"}],"version-history":[{"count":2,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/31950\/revisions"}],"predecessor-version":[{"id":31955,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/31950\/revisions\/31955"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/31953"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=31950"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=31950"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=31950"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}